November 16, 1995Open Access

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Key Points

Key points are not available for this paper at this time.

Abstract

Lowering the blood cholesterol level may reduce the risk of coronary heart disease. This double-blind study was designed to determine whether the administration of pravastatin to men with hypercholesterolemia and no history of myocardial infarction reduced the combined incidence of nonfatal myocardial infarction and death from coronary heart disease.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Shepherd et al. (Thu,) studied this question.

www.synapsesocial.com/papers/6902267382e6c353f8456cb7 — DOI: https://doi.org/10.1056/nejm199511163332001

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Modelling Survival Data in Medical Research.· 1994 · 1,025 citations
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain· 1988 · 184 citations
A coronary primary prevention study of Scottish men aged 45?64 years: Trial design· 1992 · 84 citations
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease· 1984 · 780 citations

Authors

James Shepherd

Stuart M. Cobbe

Ian Ford

Journals

New England Journal of Medicine

Actions

Institutions

University of Glasgow

Glasgow Royal Infirmary

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion